# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

# C. Measurand:

# E. Applicant:

# G. Regulatory Information:

1. Regulation section: 21 CFR 866.1640 Antimicrobial Test Powder

2. Classification: Class II

3. Product code: JWY – Manual reading of AST of ${ > } 1 6$ hours incubation LRG – Automated readings of AST of ${ > } 1 6$ hours incubation

4. Panel:

83 Microbiology

# H. Intended Use:

1. Intended use(s):

The Sensititre $^ \mathrm { \textregistered }$ 18-24 hour MIC or Breakpoint Susceptibility System is an invitro diagnostic product for clinical susceptibility testing of gram positive and gram negative organisms.

2. Indication(s) for use:

This $5 1 0 ( \mathrm { k } )$ is for addition of Minocycline in the dilution range of $0 . 0 3 { - } 3 2 \mu \mathrm { g / m L }$ for testing gram negative and gram positive isolates on the Sensititre $^ \mathrm { \textregistered }$ 18-24 hour Susceptibility system. The approved primary “Indications for Use” and clinical significance of Minocycline is for:

Aerobic and facultative Gram-negative and Gram-positive microorganisms:

E.coli   
Klebsiella spp.   
Enterobacter aerogenes Acinetobacter spp.   
Staphylococcus aureus

3. Special conditions for use statement(s):

For prescription use only.

Minocycline is not the drug of choice in the treatment of any type of staphylococcal infection.

4. Special instrument requirements:

Use Sensititre AutoInoculator for inoculation

# I. Device Description:

The Sensititre Susceptibility System is a micro-version of the classic broth dilutions method and can provide both qualitative and quantitative susceptibility results in a dried microtitre plate format. Each micro-broth dilution plate is dosed with antimicrobial agents at specific dilutions and then dried.

The organism to be tested must be in pure culture and identified as Gram negative or Gram positive. Colonies are then suspended in broth and brought to a turbidity of 0.5 McFarland, with the recommendation to use the Sensititre nephelometer. The organism suspension is diluted using Mueller-Hinton broth to a final inoculum concentration of $1 \mathrm { X } 1 0 ^ { 5 } \mathrm { C F U / m L }$ . A volume of $5 0 \mu \mathrm { l }$ of broth suspension is transferred to each well of the microtitre plate by the Sensititre AutoInoculator. After inoculation, plates are sealed with an adhesive seal, incubated at $3 4 – 3 6 ^ { \circ } \mathrm { C }$ for 18 to 24 hours and examined for bacterial growth. Antimicrobial susceptibility testing results may be read automatically using the Sensititre $^ \mathrm { \textregistered }$ AutoReader $\textsuperscript { \textregistered }$ or manually using the Sensititre $^ \mathrm { \textregistered }$ manual viewer or SensiTouch $^ \mathrm { \textregistered }$ .

# J. Substantial Equivalence Information:

1. Predicate device name(s): Siemens’ MicroScan $^ \mathrm { \textregistered }$ , Dried Gram-Negative and Gram-Positive MIC/Combo Panels

2. Predicate K number(s): K010159

3. Comparison with predicate:

<table><tr><td colspan="3" rowspan="1">Similarities</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate</td></tr><tr><td colspan="1" rowspan="1">1. Intended Use</td><td colspan="1" rowspan="1">The Sensititre® 18-24MIC or BreakpointSusceptibility system isan in vitro diagnosticproduct for clinicalsusceptibility testing ofnon-fastidious (gramnegative and grampositive organisms)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">2. Isolates</td><td colspan="1" rowspan="1">Isolated colonies fromculture used.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">3. Sample Preparation</td><td colspan="1" rowspan="1">Inoculum density of 0.5McFarland Standard</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">4. Technology</td><td colspan="1" rowspan="1">Automated based onfluorescence detection ofgrowth. Manual based onturbidity.</td><td colspan="1" rowspan="1">Turbidity detection of growthfor manual. Patentedfluorescent technology for theautomated.</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">5. Result Reported</td><td colspan="1" rowspan="1">Report results as aminimum inhibitoryconcentration (MIC) andinterpretive criteria (SIR)</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">6. Type of Test</td><td colspan="1" rowspan="1">Automated and Manual</td><td colspan="1" rowspan="1">Same</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device</td><td rowspan=1 colspan=1>Predicate</td></tr><tr><td rowspan=1 colspan=1>1. Incubation</td><td rowspan=1 colspan=1>18-24 hours</td><td rowspan=1 colspan=1>3.5-24 hours</td></tr><tr><td rowspan=1 colspan=1>2. Antibiotic</td><td rowspan=1 colspan=1>Minocycline 0.03-32µg/mL</td><td rowspan=1 colspan=1>Gatifloxacin 0.004-32μg/mL</td></tr></table>

# K. Standards/Guidance Documents referenced (if applicable):

1. Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test Systems; Guidance for Industry and FDA;   
2. CLSI M100-S18 and M100-S19: Performance Standards for Antimicrobial Susceptibility Testing;   
3. CLSI M7-A7 and M7-A8: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically.

# L. Test Principle:

The Sensititre $^ \mathrm { \textregistered }$ AutoRead $^ \mathrm { \textregistered }$ System utilizes fluorescence technology to read the micro broth dilution plates after 18 to 24 hour incubation. The technology involves the detection of bacterial growth by monitoring the activity of specific surface enzymes produced by the test organism. Growth is determined by generating a fluorescent product from a non-fluorescent (fluorogenic) substrate. The nonfluorescent substrate is prepared by conjugating a fluorescent compound to the specific enzyme substrates with a bond which prevents fluorescence. The enzymatic action of the bacterial surface enzymes on the bound non-fluorescent substrate cleaves the bond releasing the fluorescence. The amount of fluorescence detected is directly related to the activity of bacterial growth. The MIC is determined by observing the lowest dilution of antimicrobial agent that inhibits growth of the organism. The non-fluorescent (fluorogenic) substrate can be added to the inoculum broth which is dispensed into the test plate at the same time as the test organism, or, the plates can be prepared with the substrate already added to each micro-well.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

Reproducibility testing was performed using 25 Gram negative and 25 Gram positive isolates. The isolates were tested one time at each of three sites for each reading method (Manual, AutoRead $\textsuperscript { \textregistered }$ ). The testing resulted in overall reproducibility results of greater than $9 5 \%$ for both the Manual and AutoRead $^ \mathrm { \textregistered }$ methods.

b. Linearity/assay reportable range: Not Applicable   
c. Traceability, Stability, Expected values (controls, calibrators, or methods):

Isolates recommended by both the FDA(CDER) and the CLSI, namely S.aureus ATCC 29213, E.faecalis ATCC 29212, and E.coli ATCC 25922 were tested against Minocycline. Quality control was performed at all sites using both Manual and AutoRead $^ \mathrm { \textregistered }$ methods. All results were in acceptable range which demonstrates that the Sensititre Susceptibility System can consistently produce quality control results in the recommended range for Minocycline, for both the Manual and AutoRead $^ \mathrm { \textregistered }$ methods.

QC Table   

<table><tr><td rowspan=1 colspan=1>ORGANISM</td><td rowspan=1 colspan=1>Conc.(μg/mL)</td><td rowspan=1 colspan=1>Reference</td><td rowspan=1 colspan=1>Sensititre®AutoRead</td><td rowspan=1 colspan=1>Sensititre®Manual</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=4 colspan=1>S.aureus ATCC 29213Expected Range :0.06-0.5μg/mL</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>51</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>41</td></tr><tr><td rowspan=1 colspan=1>0.25</td><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>14</td></tr><tr><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>2</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=3 colspan=1>E.faecalis ATCC 29212Expected Range :1-4μg/mL</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>38</td><td rowspan=1 colspan=1>6</td></tr><tr><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>50</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>51</td></tr><tr><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>3</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=3 colspan=1>E.coli ATCC 29212Expected Range :0.25-1μg/mL</td><td rowspan=1 colspan=1>0.25</td><td rowspan=1 colspan=1>37</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>7</td></tr><tr><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>33</td><td rowspan=1 colspan=1>31</td></tr><tr><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>22</td></tr></table>

The Sensititre $^ \mathrm { \textregistered }$ nephelometer was used at each site to standardize the inoculum.   
Each time this nephelometer was turned on it underwent calibration.   
d. Detection limit: Not Applicable   
e. Analytical specificity: Not Applicable   
f. Assay cut-off: Not Applicable

2. Comparison studies:

a. Method comparison with predicate device:

The CLSI micro-broth dilution panel was prepared according to the CLSI recommendation and used as the reference method.

Clinical testing was performed at three sites using 255 Gram negative and 179 Gram positives totaling 434 isolates tested. Of the 434 isolates, 356 were fresh clinical isolates and 78 were stock challenge strains.

The growth rate for both the Manual and AutoRead $^ \mathrm { \textregistered }$ methods was greater than $90 \%$ .

Tables A-D demonstrate performance based on essential agreement and category agreement of both clinical and challenge isolates. The data is stratified by isolate Gram reaction and method of plate read (Manual or AutoRead $^ \mathrm { \textregistered }$ ).

<table><tr><td rowspan=1 colspan=1>Table A.GramNegatives/Manual Read</td><td rowspan=1 colspan=1>Tot</td><td rowspan=1 colspan=1>EAN</td><td rowspan=1 colspan=1>%EATotal</td><td rowspan=1 colspan=1>TotalEval</td><td rowspan=1 colspan=1>EAEval</td><td rowspan=1 colspan=1>%EAEval</td><td rowspan=1 colspan=1>CAN</td><td rowspan=1 colspan=1>%CA</td><td rowspan=1 colspan=1>#R</td><td rowspan=1 colspan=1>min</td><td rowspan=1 colspan=1>maj</td><td rowspan=1 colspan=1>vmj</td></tr><tr><td rowspan=1 colspan=1>Clinical</td><td rowspan=1 colspan=1>206</td><td rowspan=1 colspan=1>205</td><td rowspan=1 colspan=1>99.5</td><td rowspan=1 colspan=1>187</td><td rowspan=1 colspan=1>187</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>200</td><td rowspan=1 colspan=1>97.1</td><td rowspan=1 colspan=1>11</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Challenge</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>44</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>49</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>255</td><td rowspan=1 colspan=1>254</td><td rowspan=1 colspan=1>99.6</td><td rowspan=1 colspan=1>231</td><td rowspan=1 colspan=1>231</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>249</td><td rowspan=1 colspan=1>97.6</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td colspan="1" rowspan="1">Table B.GramNegatives/AutoRead</td><td colspan="1" rowspan="1">Tot</td><td colspan="1" rowspan="1">EAN</td><td colspan="1" rowspan="1">%EATotal</td><td colspan="1" rowspan="1">TotalEval</td><td colspan="1" rowspan="1">EAEval</td><td colspan="1" rowspan="1">%EAEval</td><td colspan="1" rowspan="1">CAN</td><td colspan="1" rowspan="1">%CA</td><td colspan="1" rowspan="1">#R</td><td colspan="1" rowspan="1">min</td><td colspan="1" rowspan="1">maj</td><td colspan="1" rowspan="1">vmj</td></tr><tr><td colspan="1" rowspan="1">Clinical</td><td colspan="1" rowspan="1">206</td><td colspan="1" rowspan="1">204</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">188</td><td colspan="1" rowspan="1">187</td><td colspan="1" rowspan="1">99.5</td><td colspan="1" rowspan="1">204</td><td colspan="1" rowspan="1">99</td><td colspan="1" rowspan="1">11</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Challenge</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">44</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">49</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">8</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Combined</td><td colspan="1" rowspan="1">255</td><td colspan="1" rowspan="1">253</td><td colspan="1" rowspan="1">99.2</td><td colspan="1" rowspan="1">232</td><td colspan="1" rowspan="1">231</td><td colspan="1" rowspan="1">99.6</td><td colspan="1" rowspan="1">253</td><td colspan="1" rowspan="1">99.2</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Table C.GramPossitiveslManual Read</td><td colspan="1" rowspan="1">Tot</td><td colspan="1" rowspan="1">EAN</td><td colspan="1" rowspan="1">%EATotal</td><td colspan="1" rowspan="1">TotalEval</td><td colspan="1" rowspan="1">EAEval</td><td colspan="1" rowspan="1">%EAEval</td><td colspan="1" rowspan="1">CAN</td><td colspan="1" rowspan="1">%CA</td><td colspan="1" rowspan="1">#R</td><td colspan="1" rowspan="1">min</td><td colspan="1" rowspan="1">maj</td><td colspan="1" rowspan="1">vmj</td></tr><tr><td colspan="1" rowspan="1">Clinical</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">149</td><td colspan="1" rowspan="1">99.3</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">149</td><td colspan="1" rowspan="1">99.3</td><td colspan="1" rowspan="1">149</td><td colspan="1" rowspan="1">99.3</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Challenge</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">29</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="1" rowspan="1">Combined</td><td colspan="1" rowspan="1">179</td><td colspan="1" rowspan="1">178</td><td colspan="1" rowspan="1">99.4</td><td colspan="1" rowspan="1">179</td><td colspan="1" rowspan="1">178</td><td colspan="1" rowspan="1">99.4</td><td colspan="1" rowspan="1">178</td><td colspan="1" rowspan="1">99.4</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Table D.GramPositives/AutoRead®</td><td rowspan=1 colspan=1>Tot</td><td rowspan=1 colspan=1>EAN</td><td rowspan=1 colspan=1>%EATotal</td><td rowspan=1 colspan=1>TotalEval</td><td rowspan=1 colspan=1>EAEval</td><td rowspan=1 colspan=1>%EAEval</td><td rowspan=1 colspan=1>CAN</td><td rowspan=1 colspan=1>%CA</td><td rowspan=1 colspan=1>#R</td><td rowspan=1 colspan=1>min</td><td rowspan=1 colspan=1>maj</td><td rowspan=1 colspan=1>vmj</td></tr><tr><td rowspan=1 colspan=1>Clinical</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>149</td><td rowspan=1 colspan=1>99.3</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>149</td><td rowspan=1 colspan=1>99.3</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Challenge</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>29</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>Combined</td><td rowspan=1 colspan=1>179</td><td rowspan=1 colspan=1>178</td><td rowspan=1 colspan=1>99.4</td><td rowspan=1 colspan=1>179</td><td rowspan=1 colspan=1>178</td><td rowspan=1 colspan=1>99.4</td><td rowspan=1 colspan=1>179</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

$\mathbf { E A } =$ Essential Agreement $\mathbf { R } =$ Resistant Isolates maj $=$ major discrepancies $\mathbf { C } \mathbf { A } =$ Category Agreement $\mathbf { m i n } =$ minor discrepancies $\mathbf { v m j } =$ very major discrepancies

Evaluable results are those that fall within the test range of the reference method and could also be on-scale with the new device if within plus/minus one dilution. Essential Agreement (EA) occurs when there is agreement between the result of the reference method and that of Sensititre $^ \mathrm { \textregistered }$ panel within plus or minus one serial two-fold dilution of the antibiotic. Category Agreement (CA) occurs when the interpretation of the result of the reference method agrees exactly with the interpretation of the Sensititre $^ \mathrm { \textregistered }$ panel result.

In each instance, both the percent Category Agreement (CA) and percent Essential Agreement (EA) consistently fall above $90 \%$ , and are therefore acceptable as described in the “Class II Special Controls guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA, August $2 0 0 9 ^ { \circ }$ . A comparative evaluation of performance data of the Manual and AutoRead methods revealed very little difference. No very major or major discrepancies occurred. A total of nine minor discrepancies occurred and all fell within Essential Agreement of the reference method result.

b. Matrix comparison:

Not Applicable

3. Clinical studies:

a. Clinical Sensitivity: Not Applicable   
b. Clinical specificity: Not Applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range:

Minocycline Interpretive Criteria: ${ < } 4$ (S), 8 (I), ${ > } 1 6$ (R)

The FDA interpretive criteria, as listed above, were used to evaluate performance all data. The appropriate Quality Control ranges, recommended QC organisms and drug interpretive criteria are included in the package insert.

# N. Proposed Labeling:

The labeling is sufficient and satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The information submitted in this premarket notification is complete and supports a substantial equivalence decision.